Diagnostic value of SHOX2 DNA methylation in lung cancer: A meta-analysis

OncoTargets and Therapy

Volumn 8, Issue , 2015, Pages 3433-3439

  Zhao, Qing Tao ^a   Guo, Tao ^a   Wang, Hui En ^a   Zhang, Xiao Peng ^a   Zhang, Hua ^a   Wang, Zhi Kang ^a   Yuan, Zheng ^a   Duan, Guo Chen ^a  

^a HEBEI GENERAL HOSPITAL   (China)

Author keywords

Diagnostic test; Lung cancer; Meta analysis; SHOX2

Indexed keywords

DNA;

ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DNA METHYLATION; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; GENE; HUMAN; LUNG ASPIRATION; LUNG CANCER; LYMPH NODE; META ANALYSIS; PLEURA EFFUSION; POLYMERASE CHAIN REACTION SYSTEM; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SHOX2 GENE; SYSTEMATIC REVIEW;

EID: 84947939223     PISSN: 11786930     EISSN: 11786930     Source Type: Journal    
DOI: 10.2147/OTT.S94300     Document Type: Article

References (37)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014; 64(1): 9-29.
2. Howlader N, Mariotto AB, Woloshin S, Schwartz LM. Providing clinicians and patients with actual prognosis: cancer in the context of competing causes of death. J Natl Cancer Inst Monogr. 2014; 2014(49): 255-264.
3. Wood DE, Kazerooni E, Baum SL, et al. Lung cancer screening, version 1.2015: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2015; 13(1): 23-34.
4. Field JK, Baldwin D, Brain K, et al. CT screening for lung cancer in the UK: position statement by UKLS investigators following the NLST report. Thorax. 2011; 66(8): 736-737.
5. Roth K, Hardie JA, Andreassen AH, Leh F, Eagan TM. Predictors of diagnostic yield in bronchoscopy: a retrospective cohort study comparing different combinations of sampling techniques. BMC Pulm Med. 2008; 8: 2.
6. Schreiber G, McCrory DC. Performance characteristics of different modalities for diagnosis of suspected lung cancer: summary of published evidence. Chest. 2003; 123(Suppl 1): S115-S128.
7. Shital P, Rujuta A, Sanjay M. Transbronchial needle aspiration cytology (TBNA) in endobronchial lesions: a valuable technique during bronchoscopy in diagnosing lung cancer and it will decrease repeat bronchoscopy. J Cancer Res Clin Oncol. 2014; 140(5): 809-815.
8. De Baere E, Speleman F, Van Roy N, De Paepe A, Messiaen L. Assignment of SHOX2 (alias OG12X and SHOT) to human chromosome bands 3q25--˃q26.1 by in situ hybridization. Cytogenet Cell Genet. 1998; 82(3-4): 228-229.
9. Clement-Jones M, Schiller S, Rao E, et al. The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome. Hum Mol Genet. 2000; 9(5): 695-702.
10. Darwiche K, Zarogoulidis P, Baehner K, et al. Assessment of SHOX2 methylation in EBUS-TBNA specimen improves accuracy in lung cancer staging. Ann Oncol. 2013; 24(11): 2866-2870.
11. Schmidt B, Liebenberg V, Dietrich D, et al. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer based on bronchial aspirates. BMC Cancer. 2010; 10: 600.
12. Ilse P, Biesterfeld S, Pomjanski N, Fink C, Schramm M. SHOX2 DNA methylation is a tumour marker in pleural effusions. Cancer Genomics Proteomics. 2013; 10(5): 217-223.
13. Kneip C, Schmidt B, Seegebarth A, et al. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma. J Thorac Oncol. 2011; 6(10): 1632-1638.
14. Schneider KU, Dietrich D, Fleischhacker M, et al. Correlation of SHOX2 gene amplification and DNA methylation in lung cancer tumors. BMC Cancer. 2011; 11: 102.
15. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003; 3: 25.
16. Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005; 58(9): 882-893.
17. Dietrich D, Kneip C, Raji O, et al. Performance evaluation of the DNA methylation biomarker SHOX2 for the aid in diagnosis of lung cancer based on the analysis of bronchial aspirates. Int J Oncol. 2012; 40(3): 825-832.
18. Dietrich D, Jung M, Puetzer S, et al. Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant and malignant pleural effusions. PLoS One. 2013; 8(12): e84225.
19. Ilse P, Biesterfeld S, Pomjanski N, Wrobel C, Schramm M. Analysis of SHOX2 methylation as an aid to cytology in lung cancer diagnosis. Cancer Genomics Proteomics. 2014; 11(5): 251-258.
20. Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med. 1993; 12(14): 1293-1316.
21. Swets JA. Measuring the accuracy of diagnostic systems. Science. 1988; 240(4857): 1285-1293.
22. Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet. 2012; 13(7): 484-492.
23. Baylin SB, Jones PA. A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer. 2011; 11(10): 726-734.
24. Tan Q, Wang G, Huang J, et al. Epigenomic analysis of lung adenocarcinoma reveals novel DNA methylation patterns associated with smoking. Onco Targets Ther. 2013; 6: 1471-1479.
25. Song L, Yu H, Li Y. Diagnosis of lung cancer by SHOX2 Gene Methylation Assay. Mol Diagn Ther. 2015; 19(3): 159-167.
26. Chu XY, Hou XB, Song WA, Xue ZQ, Wang B, Zhang LB. Diagnostic values of SCC, CEA, Cyfra21-1 and NSE for lung cancer in patients with suspicious pulmonary masses: a single center analysis. Cancer Biol Ther. 2011; 11(12): 995-1000.
27. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol. 2003; 56(11): 1129-1135.
28. Pai M, McCulloch M, Enanoria W, Colford JJ. Systematic reviews of diagnostic test evaluations: what's behind the scenes? ACP J Club. 2004; 141(1): A11-A13.
29. Jones CM, Athanasiou T. Summary receiver operating characteristic curve analysis techniques in the evaluation of diagnostic tests. Ann Thorac Surg. 2005; 79(1): 16-20.
30. Walter SD. Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat Med. 2002; 21(9): 1237-1256.
31. Chen Z, Liu HB, Yu CH, Wang Y, Wang L, Song Y. Diagnostic value of mutation-specific antibodies for immunohistochemical detection of epidermal growth factor receptor mutations in non-small cell lung cancer: a meta-analysis. PLoS One. 2014; 9(9): e105940.
32. McGee S. Simplifying likelihood ratios. J Gen Intern Med. 2002; 17(8): 646-649.
33. Gallagher EJ. Clinical utility of likelihood ratios. Ann Emerg Med. 1998; 31(3): 391-397.
34. Leeflang MM, Deeks JJ, Gatsonis C, Bossuyt PM. Systematic reviews of diagnostic test accuracy. Ann Intern Med. 2008; 149(12): 889-897.
35. Deeks JJ. Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests. BMJ. 2001; 323(7305): 157-162.
36. Coory MD. Comment on: heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol. 2010; 39(3): 932.
37. Naaktgeboren CA, van Enst WA, Ochodo EA, et al. Systematic overview finds variation in approaches to investigating and reporting on sources of heterogeneity in systematic reviews of diagnostic studies. J Clin Epidemiol. 2014; 67(11): 1200-1209.